These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27779171)

  • 1. Knockdown of Decoy Receptor 3 Impairs Growth and Invasiveness of Hepatocellular Carcinoma Cell Line of HepG2.
    Zhou XN; Li GM; Xu YC; Zhao TJ; Wu JX
    Chin Med J (Engl); 2016 Nov; 129(21):2623-2629. PubMed ID: 27779171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivo.
    Zhou J; Song S; He S; Wang Z; Zhang B; Li D; Zhu D
    Int J Mol Med; 2013 Sep; 32(3):653-60. PubMed ID: 23846297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The siRNA silencing of DcR3 expression induces Fas ligand-mediated apoptosis in HepG2 cells.
    Zhao T; Xu Y; Ren S; Liang C; Zhou X; Wu J
    Exp Ther Med; 2018 May; 15(5):4370-4378. PubMed ID: 29725377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoy receptor 3 suppresses FasL-induced apoptosis via ERK1/2 activation in pancreatic cancer cells.
    Zhang Y; Li D; Zhao X; Song S; Zhang L; Zhu D; Wang Z; Chen X; Zhou J
    Biochem Biophys Res Commun; 2015 Aug; 463(4):1144-51. PubMed ID: 26102031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
    Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M
    Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Decoy' and 'non-decoy' functions of DcR3 promote malignant potential in human malignant fibrous histiocytoma cells.
    Toda M; Kawamoto T; Ueha T; Kishimoto K; Hara H; Fukase N; Onishi Y; Harada R; Minoda M; Kurosaka M; Akisue T
    Int J Oncol; 2013 Sep; 43(3):703-12. PubMed ID: 23817777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of miR-340 on hepatocellular carcinoma by targeting the DcR3 gene.
    Xie L; Chen Z; Liu H; Guan L; Wang Z; Li W
    Dig Liver Dis; 2018 Mar; 50(3):291-296. PubMed ID: 29311025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-apoptosis Effect of Decoy Receptor 3 in Cholangiocarcinoma Cell Line TFK-1.
    Xu YC; Cui J; Zhang LJ; Zhang DX; Xing BC; Huang XW; Wu JX; Liang CJ; Li GM
    Chin Med J (Engl); 2018 Jan; 131(1):82-87. PubMed ID: 29271385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
    Zhang J; Zhang DL; Jiao XL; Dong Q
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development.
    Chen C; Zhang C; Zhuang G; Luo H; Su J; Yin P; Wang J
    Cancer Invest; 2008 Dec; 26(10):965-74. PubMed ID: 19093253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DcR3 promotes hepatoma cell migration by downregulating E-cadherin expression.
    Zhang H; Chen X; Li D; Cui L; Li X; Ye X; Wan X
    Oncol Rep; 2017 Jul; 38(1):377-383. PubMed ID: 28560426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decoy receptor 3 expression in AsPC-1 human pancreatic adenocarcinoma cells via the phosphatidylinositol 3-kinase-, Akt-, and NF-kappa B-dependent pathway.
    Chen PH; Yang CR
    J Immunol; 2008 Dec; 181(12):8441-9. PubMed ID: 19050262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The soluble Decoy Receptor 3 is regulated by a PI3K-dependent mechanism and promotes migration and invasion in renal cell carcinoma.
    Weissinger D; Tagscherer KE; Macher-Göppinger S; Haferkamp A; Wagener N; Roth W
    Mol Cancer; 2013 Oct; 12(1):120. PubMed ID: 24107265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Short hairpin RNA mediated glypican-3 silencing inhibits hepatoma cell invasiveness and disrupts molecular pathways of angiogenesis].
    Yu DD; Yao M; Chen J; Wang L; Yan MJ; Gu X; Qiu LW; Dong ZZ; Yao DF; Lu SL
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jun; 21(6):452-8. PubMed ID: 24034848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma].
    Chen G; Luo DZ; Wang Y; Liao ZL; Zhang MY
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):113-7. PubMed ID: 17493386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic pulmonary fibrosis fibroblasts become resistant to Fas ligand-dependent apoptosis via the alteration of decoy receptor 3.
    Im J; Kim K; Hergert P; Nho RS
    J Pathol; 2016 Sep; 240(1):25-37. PubMed ID: 27218286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of decoy receptor 3 in hepatocellular carcinoma and its association with resistance to Fas ligand-mediated apoptosis.
    Shen HW; Gao SL; Wu YL; Peng SY
    World J Gastroenterol; 2005 Oct; 11(38):5926-30. PubMed ID: 16273601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions.
    Hsieh SL; Lin WW
    J Biomed Sci; 2017 Jun; 24(1):39. PubMed ID: 28629361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoy receptor 3 regulates the expression of various genes in rheumatoid arthritis synovial fibroblasts.
    Fukuda K; Miura Y; Maeda T; Takahashi M; Hayashi S; Kurosaka M
    Int J Mol Med; 2013 Oct; 32(4):910-6. PubMed ID: 23912906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DcR3-TL1A signalling inhibits cytokine-induced proliferation of rheumatoid synovial fibroblasts.
    Takahashi M; Miura Y; Hayashi S; Tateishi K; Fukuda K; Kurosaka M
    Int J Mol Med; 2011 Sep; 28(3):423-7. PubMed ID: 21537832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.